Dr. Bruce L. Zuraw, MD

Dr. Zuraw practices at UCSD Hillcrest Medical Center in San Diego, California.

Dr. Zuraw's NPI, 1780634261, was assigned on May 12, 2006. Dr. Zuraw graduated from Loyola University Chicago Stritch School of Medicine in 1975. Dr. Zuraw holds California license G47065.

Dr. Zuraw's primary practice is UCSD Hillcrest Medical Center, at 200 W Arbor Dr, San Diego, CA 92103 in San Diego County. The practice phone is (619) 543-6222.

Dr. Zuraw's primary practice is UCSD Hillcrest Medical Center in San Diego, California. Dr. Zuraw is also affiliated with Hillcrest Medical Center. The medical group on file is UC San Diego Health.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Zuraw practices. Vendor and product names are available with a free account.

Allergy and immunology is Dr. Zuraw's primary specialty in the NPI Registry, under taxonomy code 207K00000X. Dr. Zuraw is board certified in allergy & immunology by the American Board of Allergy and Immunology. Dmand AI has Dr. Zuraw's licenses on file in 2 states: California and Illinois.

Dmand AI lists asthma and immune deficiency disease among the conditions Dr. Zuraw treats.

CMS counts 23 Medicare patients who saw Dr. Zuraw in 2024. 57% of them have high cholesterol. Their average risk score is 0.87, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Zuraw's median patient age at 42, with 66% women.

In 2024, Dr. Zuraw wrote 87 Medicare Part D claims for 22 patients. 59% of them were for generic drugs. CMS names the drug for 62 of them, across 5 drugs with 11 or more claims each, at $494,739 in total drug cost. In 2023, CMS named 27 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Zuraw for performance year 2024, reported as part of a group. Dr. Zuraw accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Zuraw as offering telehealth.

Dmand AI links 142 papers to Dr. Zuraw, published from 2001 to 2025. 2016 was the busiest year, with 9. The most frequent topics are Angioedemas, Hereditary, Complement C1 Inhibitor Protein and Bradykinin. Dr. Zuraw has published most often in J Allergy Clin Immunol Pract. Dr. Zuraw's most frequent co-authors are Marc Andrew Riedl, MD, Timothy J. Craig, DO and William Raymond Lumry, MD.

Dmand AI links Dr. Zuraw to 7 clinical trials, 5 of them phase 3 studies. Conditions studied include Hereditary Complement Deficiency Diseases, Angioedemas, Hereditary and Angioedema. Shire sponsors the most, 5.

CMS Open Payments shows 215 general payments to Dr. Zuraw from 13 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 51% of the total. CSL Behring paid the most, $153,765.

Dr. Zuraw graduated from Loyola University Chicago Stritch School of Medicine in 1975.

Dr. Zuraw is in network with 15 carriers, including Elevance, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.